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The global epidemiology of Haemophilus ducreyi infections 
is poorly documented because of difficulties in confirming 
microbiological diagnoses. We evaluated published data on 
the proportion of genital and nongenital skin ulcers caused 
by H. ducreyi before and after introduction of syndromic 
management for genital ulcer disease (GUD). Before 2000, 
the proportion of GUD caused by H. ducreyi ranged from 
0.0% to 69.0% (35 studies in 25 countries). After 2000, the 
proportion ranged from 0.0% to 15.0% (14 studies in 13 
countries). In contrast, H. ducreyi has been recently identi-
fied as a causative agent of skin ulcers in children in the 
tropical regions; proportions ranged from 9.0% to 60.0% (6 
studies in 4 countries). We conclude that, although there 
has been a sustained reduction in the proportion of GUD 
caused by H. ducreyi, this bacterium is increasingly recog-
nized as a major cause of nongenital cutaneous ulcers.
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SYNOPSIS
Haemophilus ducreyi, a fastidious gram-negative bac-terium, is the causative agent of chancroid, a genital 
ulcer disease (GUD). The organism is usually spread dur-
ing sexual intercourse through microabrasions, and the dis-
ease usually manifests as multiple painful superficial ulcers 
associated with inguinal lymphadenitis (1). As a result of 
the painful nature of the lesions, patients usually seek im-
mediate treatment, and asymptomatic carriage is therefore 
uncommon (2). In addition to causing GUD, H. ducreyi has 
been found in several recent studies to be a major cause of 
chronic skin ulceration in children from developing coun-
tries (3–6).
The global epidemiology of chancroid is poorly docu-
mented, and it is not included in World Health Organiza-
tion estimates of the global incidence of curable sexually 
transmitted infections (STIs). There are some key challeng-
es in interpreting data on the epidemiology of H. ducreyi as 
a causative agent of GUD. First, genital herpes cases are 
easily misdiagnosed as chancroid on clinical examination. 
Thus, reports based only on clinical diagnosis can be er-
roneous. Second, laboratory culture is technically difficult, 
and the highly sensitive and specific nucleic acid amplifica-
tion tests, such as PCR, are rarely available outside national 
reference laboratories or specialized STI research settings, 
which makes it difficult to confirm clinical diagnoses.
Determination of the true global incidence of chan-
croid is made more difficult by widespread adoption of 
syndromic management for bacterial GUD (i.e., treatment 
with antimicrobial drugs effective against syphilis and 
chancroid) without microbiological confirmation in many 
countries. Therefore, countries often report only the total 
number of GUD cases. In addition, identification of GUD 
etiology is rarely conducted in resource-poor countries to 
validate syndromic management for which chancroid could 
also be common.
Earlier studies of tropical skin ulcers did not gener-
ally test for H. ducreyi, with the exception of a small 
number of case reports (7–11). There are major limita-
tions in describing the prevalence of causative agents 
in tropical skin lesions that typically occur in children 
in rural areas where there is no access to laboratory fa-
cilities. Pathogens such as Fusobacterium fusiforme, 
Staphylococcus aureus, and Streptococcus pyogenes 
have been reported from Gram staining of exudative 
material collected from tropical ulcers (12). However, 
cultures or PCR testing for definitive identification of 
fastidious pathogens involved has not been traditionally 
conducted. The purpose of this study was to improve 
our understanding of the epidemiology of H. ducreyi in-
fection through a systematic review of published data 
on the proportion of genital and skin ulcers caused by 
this bacterium.
Methods
Search Strategy and Selection Criteria
A systematic review was conducted to identify all relevant 
studies that examined the etiology of GUD and nongenital 
skin ulcers involving H. ducreyi. We searched the National 
Library of Medicine through PubMed for “H. ducreyi,” 
“chancroid,” “genital ulcer,” OR “skin ulceration” AND 
“proportion” OR “prevalence.” The search was limited to 
studies published during January 1, 1980–December 31, 
2014. In addition, we searched references of identified arti-
cles and other databases for other articles, and we reviewed 
abstracts, titles, and selected studies potentially containing 
information on chancroid epidemiology. We contacted re-
searchers who were working with H. ducreyi to identify 
unpublished literature for inclusion. No language restric-
tions were set for searches.
The decision tree for inclusion or exclusion of articles 
is shown in Figure 1. We included studies if the propor-
tion of etiologic agents in genital ulcers and nongenital skin 
ulcers, including H. ducreyi, was confirmed by laboratory 
techniques. Clinical diagnosis of chancroid is often based 
on the appearance of the ulcer, which is characteristically 
painful, purulent, and deep with ragged, undermined edges 
(Figure 2). However, because the appearance of these ul-
cers is similar to ulcers caused by other bacteria, clinical 
diagnosis can be nonspecific or insensitive and often re-
quires laboratory confirmation (1). In addition, microscopy 
identification of typical morphologic features and serologic 
detection lack sensitivity and specificity (13,14). Thus, we 
only considered the following diagnostic methods as pro-
viding acceptable evidence of H. ducreyi infection: 1) isola-
tion and identification by culture; or 2) PCR/real-time PCR.
Data Extraction and Synthesis
For all qualifying studies, extracted data included study 
country, year of study, diagnostic test used for confirma-
tion, total number of H. ducreyi–positive cases, and sample 
size. Descriptive analyses of extracted data were conduct-
ed, and the number of H. ducreyi–confirmed cases was 
divided by the total number of cases to calculate the pro-
portion of cases caused by H. ducreyi. Studies qualifying 
for data extraction were grouped into 2 categories: studies 
conducted before 2000 and studies after 2000. This date 
separates studies before and after widespread implementa-
tion of syndromic management of GUD. Study sites were 
also plotted by geographic region. No quantitative meta-
analysis was undertaken.
Results
We identified 277 records in which we found 46 articles 
describing 49 studies on GUD that met our inclusion 
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criteria (Tables 1, 2; online Technical Appendix, http://
wwwnc.cdc.gov/EID/article/22/1/15-0425-Techapp1.
pdf). All identified studies were based on cohorts of pa-
tients attending STI clinics, including 3 studies that en-
rolled only commercial sex workers. The age group for all 
cases was adults >18 years of age, except for 3 studies in 
Zambia, South Africa, and China, which included patients 
>16 years of age, and 1 study in Madagascar, which in-
cluded patients >14 years of age. A total of 9 published 
studies and 2 unpublished reports that described nongeni-
tal skin ulcers caused by H. ducreyi were also included in 
our systematic review.
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Figure 1. Procedure for 
selecting eligible references 
on the epidemiology of 
Haemophilus ducreyi as a 
causative agent of genital 
ulcers. GUDs, genital ulcer 
disease; STI, sexually 
transmitted infections.
Figure 2. Ulcers caused by 
infection with Haemophilus 
ducreyi. A, B) Genital ulcers 
in adult patients from Ghana 
(provided by David Mabey).  
C, D) Skin ulcers in children from 
Papua New Guinea (provided by 
Oriol Mitjà).
SYNOPSIS
Laboratory confirmation of chancroid by PCR or cul-
ture was reported in 33 (67%) and 16 (32%) of the 49 stud-
ies, respectively. Of 16 studies that used culture, 7 (43%) 
used Mueller-Hinton agar with a nutritional supplement 
(e.g., IsoVitalex; Becton Dickinson, Franklin Lakes, NJ, 
USA), 1% used hemoglobin, and 5 (31%) used chocolate 
agar–based media; the remaining studies used other culture 
media. Five (31%) of 16 studies incubated agar plates at 
low temperatures (33°C–35°C), and 2 (12%) incubated 
plates at 36°C. Remaining articles did not specify incubat-
ing temperature.
Different PCR primer targets were used to amplify 
DNA sequences, including the 16S rRNA gene, the gro-
EL gene, and the hemolysin gene. In addition to herpes s 
implex virus (HSV) PCR, 23 studies used a multiplex PCR 
that could simultaneously detect the 3 major causes of 
GUD (H. ducreyi, Treponema pallidum, and HSV types 1 
and 2) (15). Studies encompassed 33 countries: 17 in Af-
rica, 4 in Southeast Asia, 3 in Europe, 2 in the Middle East, 
3 in South America, and 2 in the Caribbean, 1 in the United 
States, and 1 in Australia.
Incidence of Chancroid
Of 49 studies on chancroid analyzed, 35 were published 
during 1980–1999 (Table 1) and 14 during 2000–2014 
(Table 2). In general, data showed a clear decrease in the 
proportion of chancroid during 1980–2014 in all areas ana-
lyzed (Figure 3).
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Table 1. Characteristics of 35 studies of genital ulcers caused by Haemophilus ducreyi, 1980–1999* 
Area, reference† Country 
Year of 
study 
Diagnostic 
method 
No. patients 
with GUD 
No. cases H. 
ducreyi infection  % (95% CI) 
Africa       
 Paz-Bailey et al. (16) Botswana 1993 Culture 108 27 25.0 (17.7–33.9) 
 Steen (17) Côte d’Ivoire 1996 PCR NA NA 47 
 Mabey et al. (18) Gambia 1987 Culture 104 54 51.9 (42.4–61.2) 
 Hawkes et al. (19) Gambia 1995 M-PCR 18 8 44.4 (24.5–66.2) 
 Nsanze et al. (20) Kenya 1980 Culture 97 60 61.8 (51.9–70.9) 
 Kaul et al. (21) Kenya 1997 Culture 189 54 28.5 (22.6–35.3) 
 Morse et al. (22) Lesotho 1994 M-PCR 105 55 53.3 (43.8–62.6) 
 Harms et al. (23) Madagascar 1992 Culture 12 61 19.6 (11.6–31.3) 
 Behets et al. (24) Madagascar 1997 M-PCR 196 64 32.6 (26.4–39.5) 
 Behets et al. (25) Malawi 1995 M-PCR 778 204 26.2 (23.2–29.4) 
 Hoyo et al. (26) Malawi 1999 M-PCR 137 41 29.0 (22.8–38.0) 
 Bogaerts et al. (27) Rwanda 1992 Culture 395 115 29.1 (24.8–33.7) 
 Totten et al. (28) Senegal 1992 PCR 39 22 56.4 (40.9–70.7) 
 Crewe-Brown et al. (29) South Africa 1981 Culture 100 45 45 (35.5–54.7) 
 Dangor et al. (30) South Africa 1989 Culture 240 164 68.3 (62.2–73.8) 
 Chen et al. (31) South Africa 1994 M-PCR 538 171 31.7 (27.9–35.8) 
 Lai et al. (32) South Africa 1994 M-PCR 160 232 68.9 (62.7–74.5) 
  South Africa 1998 M-PCR 94 186 50.5 (43.4–57.6) 
 Meheus et al. (33) Swaziland 1979 Culture 155 68 43.8 (36.3–51.7) 
 Ahmed et al. (34) Tanzania 1999 PCR 102 12 11.7 (6.8–19.4) 
 Le Bacq et al. (35) Zimbabwe 1991 Culture 90 22 24.4 (16.7–34.2) 
Asia       
 Wang et al. (36) China 1999 M-PCR 96 0 0.0 (0.0–3.8) 
 Risbud et al. (37) India 1994 M-PCR 302 84 27.8 (23.0–33.1) 
 Rajan et al. (38) Singapore 1983 Culture 670 56 8·3 (6·4–10·7) 
 Beyrer et al. (15) Thailand 1996 M-PCR 38 0 0.0 (0.0–9.1) 
North America       
 Dillon et al. (39) United States 1990 Culture 82 27 32.9 (23.7–43.6) 
 Mertz et al. (40) United States 1995 M-PCR 143 56 39.1 (231.5–47.3) 
 Mertz et al. (41) United States 1996 M-PCR 516 16 3.1 (1.9–4.9) 
South America       
 Sanchez et al. (42) Peru 1995 M-PCR 61 3 4.9 (1.6–13.4) 
Caribbean       
 Sanchez et al. (42) Dominican 
Republic 
1996 M-PCR 81 21 25.9 (17.6–36.4) 
 Behets et al. (43) Jamaica 1996 M-PCR 304 72 23·6 (19.2–28.7) 
 Bauwens et al. (44) Bahamas 1992 PCR 47 7 14·8 (7.4–27.6) 
Middle East       
 Madani et al. (45) Saudi Arabia 1999 Culture 3,679 78 2.1 (1.7–2.5) 
Europe       
 Kyriakis et al. (46) Greece 1996 Culture 695 32 4.6 (3.2–6.4) 
 Bruisten et al. (47) The Netherlands 1996 M-PCR 368 3 0.8 (0.2–2.3) 
*GUD, genital ulcer disease; NA, not available; M-PCR, multiplex PCR. 
†References 41–47 provided in the online Technical Appendix (http://wwwnc.cdc.gov/EID/article/22/1/15-0425-Techapp1.pdf). 
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During 1980–1999, the proportion of genital ul-
cers caused by H. ducreyi in these studies ranged from 
0.0% in Thailand and China to 68.9% in South Africa 
(Table 1). Eleven (31.4%) studies reported high propor-
tions (>40%) of cases of infection with H. ducreyi. All 
of these studies were conducted in countries in Africa 
(Côte d’Ivoire, Gambia, Kenya, Lesotho, Senegal, South 
Africa, and Swaziland). Slightly lower proportions 
(20%–40% of cases) were observed in 15 (42%) studies: 
10 in countries in Africa, 2 in the United States during 
localized outbreaks, 1 in Jamaica, 1 in the Dominican 
Republic, and 1 in India.
Only a few countries reported low proportions 
(<10%) of genital ulcers infected with H. ducreyi, in-
cluding Singapore (8.3%), Peru (5%), Greece (4.6%), 
the Netherlands (0.9%), United States (3.1%), and Saudi 
Arabia (2.1%). The study in Saudi Arabia was conducted 
during 1995–1999; a total of 27,490 patients were ex-
amined for STIs. Chancroid was diagnosed by culture 
and was reported as the least common STI during this 
survey. The only studies that reported no cases of chan-
croid were conducted in Thailand in 1996 and China in 
1999; both studies used multiplex PCR for detection of 
GUD cases.
During 2000–2014, the proportion of H. ducreyi infec-
tions was low (<10%) in all studies analyzed, except for 
1 study in Malawi (15%) (Table 2). Studies in 5 countries 
(Kenya, Namibia, Zambia, Brazil, and Australia) did not 
report any cases of infection with H. ducreyi. Other stud-
ies reporting proportions of infections <10% were con-
ducted in Botswana, Mozambique, South Africa, Uganda, 
Pakistan, and France. No reports were found for studies in 
North America, Southeast Asia, or the Caribbean.
Nongenital Skin Infections with H. ducreyi
During 1988–2010, several case reports described 4 chil-
dren and 4 adults with nonsexually transmitted infections 
with H. ducreyi that manifested as lower leg lesions but no 
genital lesions. The reported case-patients were travelers 
who had been to Fiji (7), Samoa (8), Vanuatu (9), or Papua 
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Table 2. Characteristics of 14 studies of genital ulcers caused by Haemophilus ducreyi, 2001–2014* 
Area, reference† Country 
Year of 
study 
Diagnostic 
method 
No. patients 
with GUD 
No. cases  
H. ducreyi infection  % (95% CI) 
Africa       
 Paz-Bailey et al. (16) Botswana 2002 PCR 137 1 0.7 (0.1–4.0) 
 Mehta et al. (48) Kenya 2007 M-PCR 59 0 0.0 (0.0–6.1) 
 Phiri et al. (49) Malawi 2006 M-PCR 398 60 15.0 (11.8–18.9) 
 Zimba et al. (50) Mozambique 2005 PCR 79 3 3.8 (1.3–10.9) 
 Tobias et al. (51) Namibia 2007 PCR 199 0 0.0 (0.0–1.8) 
 O’Farrell et al. (52) South Africa 2004 M-PCR 162 2 1.2 (0.3–4.6) 
 Lewis et al. (53) South Africa 2006 M-PCR 613 10 1.6 (0.9–2.9) 
 Nilsen et al. (54) Tanzania 2001 PCR 232 12 5.1 (2.9–8.8) 
 Suntoke et al. (55) Uganda 2006 M-PCR 100 2 2.0 (0.5–7.0) 
 Makasa et al. (56) Zambia 2010 PCR 200 0 0 (0.0–1.8) 
South America       
 Gomes Naveca et al. (57) Brazil 2009 PCR 434 0 0 (0.0–0.8) 
Middle East       
 Maan et al. (58) Pakistan 2009 Culture 521 20 3.8 (2.5–5.8) 
Europe       
 Hope-Rapp et al. (59) France 2005 Culture 278 8 2.8 (1.4–5.5) 
Oceania       
 Mackay et al. (60) Australia 2002 M-PCR 64 0 0.0 (0.0–5.6) 
*GUD, genital ulcer disease; M-PCR, multiplex PCR. 
†References 48–60 provided in the online Technical Appendix (http://wwwnc.cdc.gov/EID/article/22/1/15-0425-Techapp1.pdf). 
 
Figure 3. Trend of proportion of genital ulcers caused by 
infections with Haemophilus ducreyi, 1979–2010.
SYNOPSIS
New Guinea (10) (Table 3). Outside the south Pacific re-
gion, a 5-year-old refugee from Sudan who had lower leg 
ulceration was also given a diagnosis of infection with H. 
ducreyi (11).
A cohort study conducted in Papua New Guinea in 
2014 showed evidence that H. ducreyi is a major cause of 
chronic skin ulceration; H. ducreyi DNA was identified by 
PCR in 60.0% of skin lesions in children (3). Similar stud-
ies in other areas reported laboratory-confirmed skin ulcers 
in children caused by H. ducreyi in Papua New Guinea (6), 
Solomon Islands (4), Vanuatu (C.Y. Chen, pers. comm.), 
and Ghana (5) (Table 3).
Discussion
Our review confirmed 2 major findings. First, reduction in 
the proportion of genital ulcers caused by H. ducreyi has 
been sustained for the past decade and a half. Second, there 
is increasing evidence that H. ducreyi is a common and 
newly recognized causative agent of chronic skin ulcer-
ation in children from developing countries.
In the 1990s, the global prevalence of chancroid was 
estimated to be 7 million (17). Chancroid was one of 
the most prevalent GUDs, particularly in resource-poor 
countries in Africa, Asia, Latin America, and the Ca-
ribbean (1; reference 51 in online Technical Appendix). 
Recommendations to introduce syndromic management 
for treatment of GUD caused by bacteria were published 
by the World Health Organization in 1991 and fully 
implemented by 2000 (reference 61 in online Technical 
Appendix). Since that time, global incidence of GUDs, 
particularly chancroid, has decreased substantially, and 
genital herpes viruses (HSV-1 and HSV-2) have be-
come the predominant cause of GUD (reference 53 in 
online Technical Appendix). Currently in Europe and 
the United States, chancroid is restricted to rare sporadic 
cases. Transmission of H. ducreyi remains ongoing in 
only a few countries that have limited access to health 
services (2,6).
Our data show marked decreases in the proportion of 
GUD caused by H. ducreyi in several countries. Spinola 
et al. reported similar conclusions obtained from 25 PCR-
based studies (reference 62 in online Technical Appendix). 
For example, in Botswana (16), Kenya, (20), and South Af-
rica (29), the proportion of GUD caused by H. ducreyi de-
creased from 25%–69% to negligible (0.0%–1.2%) levels 
(16; references 48,52 in online Technical Appendix). Stud-
ies in Zambia (reference 56 in online Technical Appendix), 
Namibia (reference 51 in online Technical Appendix), and 
China (36) did not report any cases of chancroid during 
2000–2009. A study in Thailand reported elimination of 
chancroid by introduction of a condom use program in the 
1990s (reference 63 in online Technical Appendix). Simi-
lar decreases have been reported from Cambodia and Sri 
Lanka, with rapid elimination of chancroid and congenital 
syphilis in most settings (reference 63 in online Technical 
Appendix). However, these findings should be interpreted 
with caution because, given the short duration of infectiv-
ity, even a low prevalence of H. ducreyi in a population 
with GUD implies that a reservoir of infected persons with 
a high rate of sex partners is present.
Recent research has identified H. ducreyi as a previ-
ously unrecognized cause of nongenital skin ulcers in tropi-
cal areas. In 2013–2015, six studies in Papua New Guinea 
(3,6), the Solomon Islands (4), Vanuatu (C.Y. Chen et al., 
pers. comm.), and Ghana (5; C.Y. Chen et al., pers. comm.) 
showed that a high proportion of laboratory-confirmed skin 
ulcers were caused by H. ducreyi. Nearly half of the 690 
enrolled patients with ulcers in these 6 studies had H. du-
creyi detectable by PCR, whereas other bacteria, such as 
T. pallidum subsp. pertenue, the causative agent of yaws, 
were detected in 25% of patients.
These cases of infection with H. ducreyi confirmed by 
molecular analysis suggest that clinicians should be more 
aware of this newly recognized bacterium in skin ulcers 
of persons in tropical areas. In the context of new efforts 
to eradicate yaws, mass treatment with azithromycin in 
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Table 3. Characteristics of 11 studies on skin ulcers caused by Haemophilus ducreyi, 1988–2014* 
Reference Country 
Year of 
study 
Diagnostic 
method 
No. patients with 
skin ulcers 
No cases H. 
ducreyi infection % (95% CI) 
Marckmann et al. (7) Fiji Islands 1988 Culture 1 man 1 NA 
Ussher et al. (8) Samoa 2005 PCR 3 girls <10 y of age 3 NA 
McBride et al. (9) Vanuatu 2007 PCR 1 woman 1 NA 
Peel et al. (10) Vanuatu and Papua 
New Guinea 
2010 PCR 2 men 2 NA 
Humphrey et al. (11) Sudan 2007 PCR 1 boy 1 NA 
Mitjà et al. (3) Papua New Guinea 2013 PCR 90 54 60.0 (49.6–69.5) 
Mitjà et al. (6) Papua New Guinea 2014 PCR 114 60 60.1 (54.3–65.5) 
Marks et al. (4) Solomon Islands 2013 PCR 41 13 31.7 (19.5–46.9) 
Chen et al.† Vanuatu 2013 PCR 176 68 38.6 (31.7–46.0) 
Chen et al.† Ghana 2013 PCR 179 49 27.3 (21.3–34.3) 
Ghinai et al. (5) Ghana 2014 PCR 90 8 8.8 (4.5–16.5) 
*NA, not applicable. 
†Pers. comm.  
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Papua New Guinea reduced the absolute prevalence of ul-
cers not caused by yaws, which were mainly caused by H. 
ducreyi, from 2.7% to 0.6% (prevalence ratio 0.23, 95% CI 
0.18–0.29) at 12 months after treatment (6). However, per-
sistence of H. ducreyi at low levels after mass treatment in 
Papua New Guinea (3) and Ghana (5) suggest that 1 round 
of mass treatment might not be successful in eradicating H. 
ducreyi skin ulcers.
Our review has several limitations. First, the increase 
in HSV-related GUD as a result of immunosuppression 
by HIV infection would result in a decrease in the propor-
tion of chancroid among all GUD case-patients. Second, 
the lack of sequential studies performed in similar clini-
cal settings at multiple time points precludes an optimal 
interpretation of the apparent decrease. Third, results might 
be affected by poor-quality data from many developing 
countries and might be inflated by publication bias. Fourth, 
PCR is more sensitive than culture. Therefore, increasing 
diagnostic yield might have partially masked the scale of 
the decrease in H. ducreyi as a cause of GUD.
In summary, we observed a quantitative and sustained 
reduction in cases of chancroid as a result of antimicrobial 
drug syndromic management and major social changes. In 
addition, data from several research groups indicate that 
H. ducreyi can cause nongenital skin lesions in persons 
residing in different regions. Further studies of this newly 
described pathogen skin disease association are required, 
and appropriate policies are needed that include the routine 
practice of managing tropical skin ulcers.
M.M. is supported by a Wellcome Trust Clinical Research  
Fellowship (WT102807).
Ms. González-Beiras is a predoctoral fellow at Instituto de 
Higiene e Medicina Tropical, Lisbon, Portugal. Her primary 
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tropical diseases.
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